Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Blaise D"'
Autor:
Sanz, Jaime, Galimard, J.E., Labopin, M., Afanasyev, B., Angelucci, E., Ciceri, F., Blaise, D., Cornelissen, J.J., Meijer, E., Diez-Martin, J.L., Koc, Y., Rovira Tarrats, Montserrat, Castagna, L., Savani, B.N, Ruggeri, A., Nagler, A., Mohty, M., Universitat Autònoma de Barcelona
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Journal of hematology & oncology, 13(1):46. BioMed Central
JOURNAL OF HEMATOLOGY & ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-13 (2020)
Sanz, J, Galimard, J E, Labopin, M, Afanasyev, B, Angelucci, E, Ciceri, F, Blaise, D, Cornelissen, J J, Meijer, E, Diez-Martin, J L, Koc, Y, Rovira, M, Castagna, L, Savani, B, Ruggeri, A, Nagler, A, Mohty, M & Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 2020, ' Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia : a comparative study of the ALWP EBMT ', Journal of hematology & oncology, vol. 13, no. 1, 46 . https://doi.org/10.1186/s13045-020-00882-6
Journal of Hematology & Oncology
Journal of Hematology & Oncology, 13(1):46. BioMed Central Ltd.
Universitat Autònoma de Barcelona
Journal of hematology & oncology, 13(1):46. BioMed Central
JOURNAL OF HEMATOLOGY & ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-13 (2020)
Sanz, J, Galimard, J E, Labopin, M, Afanasyev, B, Angelucci, E, Ciceri, F, Blaise, D, Cornelissen, J J, Meijer, E, Diez-Martin, J L, Koc, Y, Rovira, M, Castagna, L, Savani, B, Ruggeri, A, Nagler, A, Mohty, M & Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 2020, ' Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia : a comparative study of the ALWP EBMT ', Journal of hematology & oncology, vol. 13, no. 1, 46 . https://doi.org/10.1186/s13045-020-00882-6
Journal of Hematology & Oncology
Journal of Hematology & Oncology, 13(1):46. BioMed Central Ltd.
BackgroundThe use of post-transplant cyclophosphamide (PTCy) is highly effective in preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting and is being increasingly used in matched sibling (MSD) and matched unrel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6219eb6b70b04985a207e70bdde2ae04
https://ddd.uab.cat/record/236424
https://ddd.uab.cat/record/236424
Autor:
Schmid, C., Labopin, M., Schaap, N., Veelken, H., Schleuning, M., Stadler, M., Finke, J., Hurst, E., Baron, F., Ringden, O., Bug, G., Blaise, D., Tischer, J., Bloor, A., Esteve, J., Giebel, S., Savani, B., Gorin, N.C., Ciceri, F., Mohty, M., Nagler, A., EBMT Acute Leukaemia Working Party
Publikováno v:
British Journal of Haematology, 184, 5, pp. 782-787
British Journal of Haematology, 184(5), 782-787. WILEY
British Journal of Haematology, 184, 782-787
British Journal of Haematology, 184(5), 782-787. WILEY
British Journal of Haematology, 184, 782-787
Strategies for relapse prevention after allogeneic transplantation in acute leukaemia are warranted. A registry-based matched-pair analysis evaluated the efficacy of prophylactic donor lymphocyte infusion (proDLI). Adults receiving proDLI in complete
Autor:
Craddock, C, Versluis, J, Labopin, M, Socie, G, Huynh, A, Deconinck, E, Volin, L, Milpied, N, Bourhis, JH, Rambaldi, A, Chevallier, P, Blaise, D, Manz, M, Vellenga, E, Vekemans, MC, Maertens, J, Passweg, J, Vyas, P, Schmid, C, Löwenberg, B, Ossenkoppele, G, Mohty, M, Cornelissen, JJ, Nagler, A, HOVON‐SAKK, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and
Publikováno v:
Journal of Internal Medicine, 283(4), 371-379. Wiley
Journal of Internal Medicine, Vol. 283, no. 4, p. 371-379 (2018)
Journal of Internal Medicine, 283(4), 371-379. Wiley-Blackwell Publishing Ltd
Journal of Internal Medicine, Vol. 283, no. 4, p. 371-379 (2018)
Journal of Internal Medicine, 283(4), 371-379. Wiley-Blackwell Publishing Ltd
Background. Disease recurrence remains the major cause of death in adults with acute myeloid leukaemia (AML) treated using either intensive chemotherapy (IC) or allogenic stem cell transplantation (allo-SCT).Aims. The timely delivery of maintenance d
Autor:
Schmid, C, Labopin, M, Socie, G, Daguindau, E, Volin, L, Huynh, A, Bourhis, J H, Milpied, N, Cornelissen, Jan, Chevallier, P, Maertens, J, Jindra, P, Blaise, D, Lenhoff, S, Ifrah, N, Baron, F, Ciceri, F, Gorin, C, Savani, B, Giebel, S, Polge, E, Esteve, J, Nagler, A, Mohty, M, Acute Leukemia Party, Europ
Publikováno v:
Blood, 126(17), 2062-2069. American Society of Hematology
Patients with cytogenetically normal acute myeloid leukemia (CN-AML) can be subdivided by molecular mutations. However, data on the influence of combinations of different aberrations on outcome after allogeneic hematopoietic stem cell transplantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84ab5b4a692bc83a8c17b9b667565d9c
https://pure.eur.nl/en/publications/ece76121-e199-4d67-b9c8-5578abe0ed21
https://pure.eur.nl/en/publications/ece76121-e199-4d67-b9c8-5578abe0ed21
Autor:
Passweg, J.R., Labopin, M., Cornelissen, J., Volin, L., Socie, G., Huynh, A., Tabrizi, R., Wu, D., Craddock, C., Schaap, N.P., Kuball, J., Chevallier, P., Cahn, J.Y., Blaise, D., Ghavamzadeh, A., Bilger, K., Ciceri, F., Schmid, C., Giebel, S., Nagler, A., Mohty, M.
Publikováno v:
Bone Marrow Transplantation, 50, 1063-8
Bone Marrow Transplantation, 50(8), 1063-1068. Nature Publishing Group
Bone Marrow Transplantation, 50, 8, pp. 1063-8
Bone Marrow Transplantation, 50(8), 1063. Nature Publishing Group
Bone Marrow Transplantation, 50(8), 1063-1068. Nature Publishing Group
Bone Marrow Transplantation, 50, 8, pp. 1063-8
Bone Marrow Transplantation, 50(8), 1063. Nature Publishing Group
Contains fulltext : 152063.pdf (Publisher’s version ) (Closed access) In recipients of allogeneic hematopoietic stem cell transplantation with AML in CR1, reduced intensity (RIC) conditioning regimens are usually given to older patients and myeloab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f6641137b10f355dbe67461606302e9
http://hdl.handle.net/2066/152063
http://hdl.handle.net/2066/152063
Autor:
Gorin NC, Labopin M, Reiffers J, Milpied N, Blaise D, Witz F, de Witte T, Meloni G, Attal M, Bernal T, Rocha V, Acute Leukemia Working Party, European Cooperative Group for Blood, Marrow Transplantation, MARTINELLI, GIOVANNI
Publikováno v:
Europe PubMed Central
Blood, 116, 3157-62
Blood, 116, 17, pp. 3157-62
Blood, 116, 3157-62
Blood, 116, 17, pp. 3157-62
Contains fulltext : 88340.pdf (Publisher’s version ) (Closed access) The stem cell source for autologous transplantation has shifted from bone marrow to peripheral blood (PB). We previously showed that relapse incidence in patients with acute myelo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::146991c4debad19d6eef4f22c3b8c909
http://hdl.handle.net/11573/89753
http://hdl.handle.net/11573/89753
Autor:
Gorin N.C., Labopin M., Rocha V., Arcese W., Beksac M., Gluckman E., Ringden O., Ruutu T., Reiffers J., Bandini G., Falda M., Zikos P., Willemze R., Frassoni F., Abecasis M., Abráhamová J., Afanassiev B.V., Aglietta M., Alabdulaaly A., Aleinikova O., Paolo Alessandrino E., Al Shemmari S.H., Amadori D., Amadori S., Amos T., Andolina M., Andreesen R., Angelucci E., Anhuf J., Arnold R., Arpaci F., Attal M., Azevedo W., Azim H.A., Baccarani M., Bacigalupo A., Barbui T., Bargetzi M., Barnard D.L., Bartsch H.H., Baruchel A., Battista C., Bay J.-O., Bayik M., Bazarbachi A., Beguin Y., López J.L.B., Benedek I., Benedetti F., Bengala C., Berrebi A., Besalduch J., Biesma D., Biron P., Björkholm M., Blaise D., Blesing N.E., Boasson M., Bobev D., Boccadoro M., Bolaman Z., Boogaerts M.A., Bordessoule D., Bosi A., Aida B.S., Bourhis J.H., Bourikas G., Bowen D.T., Bregni M., Bries G., Brinch L., Brittain D., Bron D., Brune M., Bullorsky E.O., Bunjes D., Burdach S., Burnett A.K., Buzyn A., Caballero D., Cagirgan S., Cahn J.-Y., Canepa C.O., Cao A., Carella A.M., Carrera F.D., Carret A.-S., Cascinu S., Castel V., Caswell M., Cavanna L., Cetto G.L., Chapuis B., Chasty R., Chen Y.-C., Chisesi T., Chopra R., Chybicka A., Clark R.E., Colombat P., Colovic M.D., Constenla-Figueiras M., Contreras M., Contu L., Cordonnier C., Cornelissen J.J., Cornish J., Coser P., Costa N., Coze C., Craddock C., Crown J., Culligan D.J., Danova M., Darbyshire P.J., Davies J.M., de Bock R., de Pablos Gallego J.M., De Prijck B., de Revel T., De Rossi G., De Souza C.A., Deb G., Degos L., Demuynck H., Dervenoulas I., Di Bartolomeo P., Di Renzo N., Diaz M.A., Diehl V., Diez-Martin J.L., Dincer S., Giorgio D., Dmoszynska A., Doelken G., Peter P.D., Dulley F., Easow J., Ebell W., Efremidis A., Ehninger G., Eichler H., Eimermacher H., Enno A., Errazquin L., Aguado J.E., Everaus H., Fagioli F., Fanin R., Fassas A., Fasth A., Faulkner L.B., Fauser A.A., Feldman L., Feremans W., Ferhanoglu B., Fernández M.N., Fernández-Ranada J.M., Ferrant A., Ferrara F., Finke J., Fischer A., Fischer J., Fitzsimons T., Floristan F., Forjaz de Lacerda J.M.F., Fossati-Bellani F., Fosser V., Franklin I., Freund M., Frickhofen N., Gabbas A., Gadner H., Gallamini A., Galvin M.C., López J.G., García-Conde J., Gaska T., Gastl G., Gedikoglu G., Ghavamzadeh A., Gianni A., Gibson B.E., Gil J.L., Gilleece M.H., Gisselbrecht C., Glass B., Gmür J., Göbel U., Goldman J.M., Goldstone A.H., San Miguel J.D.G., González-López M.-A., Grafakos S., Gramatzki M., Grañena A., Gratecos N., Gratwohl A., Greinix H.T., Gugliotta L., Guilhot F., Guimaraes J.E., Gülbas Z., Gulyuz O., Gurman G., Gutierrez M.M., Haas R., Hamladji R.-M., Hamon M.D., Hansen N.E., Harhalakis N., Harousseau J.L., Hartenstein R., Hartmann C.O., Hausmaninger H., Haznedar R., Heit W., Hellmann A., Herrmann R.P., Hertenstein B., Hess U., Hinterberger W., Ho A.D., Hoelzer D., Holowiecki J., Horst H.-A., Hossfeld D.K., Huebsch L., Hunter A.E., Iacopino P., Iannitto E., Indrák K., Iriondo A., Izzi T., Jackson G.L., Jacobs P., Jacobsen N., Janvier M., Jebavy L., Joensuu H., Joerg S., Jones F.G.C., Jouet J.P., Joyner M.V., Juliusson G., Jürgens H., Kalayoglu-Besisik S., Kalman N., Kalmanti M., Kansoy S., Kansu E., Kanz L., Karianakis G., Kernéis Y., Khalifeh O., Khomenko V., Kienast J., Killick S., Kirchner H.H., Klingebiel T., Knauf W., Koenigsmann M., Koistinen P., Koivunen E., Kolb H.-J., Kolbe K., Koller E., Komarnicki M., Koscielniak E., Kovacsovics T., Kowalczyk J.R., Koza V., Kozak T., Kugler J., Kuliczkowski K., Kvaloy S., Labar B., Laciura P., Palacios J.J.L., Lakota J., Lambertenghi D.G., Lange A., Lanza F., Isasti R.L., Lauria F., Le Moine F., Leblond V., Lelli G., Lenhoff S., Leon L.A., Leoncini-Franscini L., Leone G., Leoni P., Levis A., Leyvraz S., Liberati M., Link H., Linkesch W., Liso V., Lisukov I.A., Littlewood T., Ljungman P., Locatelli F., Losonczy H., Lotz J.-P., Ludwig H., Lukac J., Lutz D., Macchia P., Madrigal A., Maiolino A., Majolino I., Eloy-García J.M., Malesevic M., Mandelli F., Marc A., Marcus R., Marianska B., Markuljak I., Marsh J.C.W., Martelli M.F., Marti Tutusaus J.M., Martin S., Martin M., Martinelli G., Martínez-Rubio A.M., Martoni A., Maschan A., Maschmeyer G., Masszi T., Mazza P., McCann S., Meier C.R., Messina C., Mettivier V., Metzner B., Michallet M., Michieli M., Michon J., Milligan D.W., Milone J.H., Giuseppe G.M., Minigo H., Mistrik M., Moicean A.D., Monfardini S., Montserrat E., Moraleda Jimenez J.M., Morales-Lazaro A., Morandi S., Morra E., Mufti G.J., Musso M., Nagler A., Nalli G., Naparstek E., Narni F., Nenadov-Beck M., Neubauer A., Newland A.C., Niederwieser D., Niethammer D., Noens L.A., Nousiainen T., Novik A., Novitzky N., Occhini D., Odriozolas J., Ojanguren J.M., O’meara A., Onat H., Orchard K., Ortega J.J., Osieka R., Ossenkoppele G.J., Othman B., Ovali E., Ozcebe O.I., Ozerkan K., Ozturk A., Papatryfonos A., Parker J.E., Pastore M., Patrone F., Patton N., Pejin D., Peñarrubia M.J., Equiza E.P., Peschel C., Pession A., Pigaditou A., Pignon B., Pihkala U., Pimentel P., Pitini V., Podoltseva E., Pogliani E.M., Anna A.P., Porta F., Potter M., Powles R., Prentice G.H., Pretnar J., Ptushkin V., Quarta G., Reiter A., Remes K., Reykdal S., Santasusana J.M.R., Rifón J., Rio B., Rizzoli V., Robak T., Robinson A.J., Rodeghiero F., Rodríguez Fernández J.M., Rombos Y., Romeril K.R., Rosenmayr A., Rossi J.F., Rosti G., Rotoli B., Rowe J.M., Russell N.H., Ryzhak O., Rzepecki P., Saglio G., Salwender H., Samonigg H., Santoro A., Sanz M.A., Sayer H.G., Scanni A., Schaafsma M.R., Schaefer U.W., Schanz U., Schattenberg A., Schey S.A.M., Schlimok G., Schmoll H.-J., Schots R., Schouten H., Schwarer A.P., Schwerdtfeger R., Scimè R., Segel E., Seger R., Selleslag D., Serban M., Shamaa S., Shaw P.J., Siegert W., Siena S., Sierra J., Simonsson B., Singer C.R.J., Sirchia G., Skotnicki A.B., Slavin S., Snowden J., Sotto J.J., Tanyeli A., Tedeschi L., Tidefelt U., Tissot J.-D., Tobler A., Tomas J.F., Torres J.P., Torres G.A., Touraine J.-L., Trneny M., Uderzo C., Unal E., Unal A., Undar L., Urban C., Van den Berg H., van Marwijk K.M., Vellenga E., Venturini M., Verdonck L.F., Veys P., Vilardell J., Vinante O., Visani G., Vitek A., Vivancos P., Volpe E., Vora A., Vorlicek J., Vowels M., Vujic D., Wachowiak J., Wagner T., Wahlin A., Walewski J., Wandt H., Weissinger F., Wijermans P.W., Wiktor-Jedrzejczak W., Will A.M., Woell E., Wörmann B., Yaniv I., Yesilipek M.A., Yilmaz U., Yong A., Zachée P., Zambelli A., Zander A.R., Zintl F., Zoumbos N.C.
PubMed ID: 12829583
Several studies have compared bone marrow (BM) and peripheral blood (PB) as stem cell sources in patients receiving allografts, but the cell doses infused have not been considered, especially for BM. Using the ALWP/EBMT regis
Several studies have compared bone marrow (BM) and peripheral blood (PB) as stem cell sources in patients receiving allografts, but the cell doses infused have not been considered, especially for BM. Using the ALWP/EBMT regis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eb575e927d75b44655a84e24d51b01e
https://hdl.handle.net/20.500.12605/17263
https://hdl.handle.net/20.500.12605/17263
Autor:
Leo Luznik, Luca Vago, Dietrich W. Beelen, Elisa Montaldo, Matteo Barcella, Robert Zeiser, Bernhard Gentner, Gabriele Bucci, Raynier Devillier, Renato Ostuni, Matteo Carrabba, Masahiro Onozawa, Valentina Gambacorta, Orietta Spinelli, Miguel Waterhouse, Katharina Fleischhauer, Elia Stupka, Ivana Gojo, Chiara Bonini, Cristina Toffalori, Lara Crucitti, Laura Zito, Raffaella Greco, Michela Riba, Matteo Maria Naldini, Dejan Lazarevic, Massimo Bernardi, Maddalena Noviello, Davide Cittaro, Takanori Teshima, Didier Blaise, Jacopo Peccatori, Cristina Barlassina, Francesco Manfredi, Giovanni Tonon, Giacomo Oliveira, Alessandro Rambaldi, Constantijn J.M. Halkes, Marieke Griffioen, Maher Hanoun, Nicoletta Cieri, Fabio Ciceri, Jürgen Finke
Transplantation of hematopoietic cells from a healthy individual (allogeneic hematopoietic cell transplantation (allo-HCT)) demonstrates that adoptive immunotherapy can cure blood cancers: still, post-transplantation relapses remain frequent. To expl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4c267055696702de8b672501c386236
http://www.nature.com/nm/index.html
http://www.nature.com/nm/index.html
Autor:
Matthias Edinger, Arnold Ganser, Annalisa Ruggeri, Martin Gramatzki, Arnon Nagler, Myriam Labopin, Patrice Chevallier, Nicolaus Kröger, Eolia Brissot, Didier Blaise, Bipin N. Savani, Fabio Ciceri, Jürgen Finke, Mohamed A. Kharfan-Dabaja, Jaime Sanz, Matthias Stelljes, Eric Deconinck, Mohamad Mohty
Publikováno v:
BRITISH JOURNAL OF HAEMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
British Journal of Haematology
British Journal of Haematology, 2021, 193 (3), pp.592-601. ⟨10.1111/bjh.17426⟩
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
British Journal of Haematology
British Journal of Haematology, 2021, 193 (3), pp.592-601. ⟨10.1111/bjh.17426⟩
Optimal donor choice for a second allogeneic haematopoietic cell transplant (allo-HCT) in relapsed acute myeloid leukaemia (AML) remains unknown. We compared overall survival (OS) using registry data from the Acute Leukemia Working Party (ALWP) of th
Autor:
Thomas Luft, Wolfgang Bethge, Liisa Volin, Didier Blaise, Patrice Chevallier, Ghulam J. Mufti, Ibrahim Yakoub-Agha, Avichai Shimoni, Nicolaus Kröger, Rainer Schwerdtfeger, Fabio Ciceri, Dietrich W. Beelen, Arnon Nagler, Arnold Ganser, Linda Koster, Simona Iacobelli, Theo de Witte, Marie Robin
Publikováno v:
British Journal of Haematology, 195, 3, pp. 417-428
British Journal of Haematology, 195, 417-428
British Journal of Haematology, 195, 417-428
Allogeneic haematopoietic-cell transplantation (allo-HCT) is a potentially curative therapy for high-risk myelodysplastic syndrome (MDS). Reduced-intensity conditioning (RIC) is usually associated with lower non-relapse mortality (NRM), higher relaps